PAA 2.33% 21.0¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-95

  1. 301 Posts.
    lightbulb Created with Sketch. 168
    Quick question for the more learned amongst up please. This is the only active thread at the moment, so going to post it here.

    There was idle chitchat about a takeover and how that might effect the options (ie any takeover would not include them) and whilst I don't think that's anywhere near a close possibility, given the options are all I'm currently holding, here's my question (and yep, it sounds like a real newb one):

    Any takeover of substance will need shareholder approval presumably, therefore a general meeting with sufficient lead time and one would suspect no halt or suspension while we await that....so, plenty of time (in theory) to convert the options and then be included in said takeover (if approved and of course assuming the takeover offer exceeds current value of the options).

    would that be correct? Or, given any pending takeover, is there a way for a company to suspend the options while a takeover is going on, and therefore excluding them from being converted and jumping into the sale pool as normal shares? would be a dog act given they are supposed to be 'reward' options but just want to understand where my holding might stand in the unlikely event of a sudden takeover.

    NZT did allude to something in one of his posts, but not quite an answer to this exact question from memory.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 21.0¢ $85.73K 407.4K

Buyers (Bids)

No. Vol. Price($)
2 53482 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 278844 4
View Market Depth
Last trade - 15.15pm 19/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.